Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Geigert

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Developments in Biological Standardization|January 1, 1997
Appropriate specifications at the IND stageJ Geigert
PDA Journal of Pharmaceutical Science and Technology|March 1, 1997
Appropriate specifications at the IND stageJ Geigert
Journal of Parenteral Science and Technology : a Publication of the Parenteral Drug Association|September 1, 1989
Overview of the stability and handling of recombinant protein drugsJ Geigert
Biochemical Society Symposium|January 1, 1983
Biological halogenation and epoxidationS L Neidleman, J Geigert
Pharmaceutical Biotechnology|January 1, 1996
Development and shelf-life determination of recombinant human granulocyte--macrophage colony-stimulating factor (LEUKINE, GM-CSF)J Geigert, F D Ghrist
Endeavour|January 1, 1987
Biological halogenation: roles in nature, potential in industryS L Neidleman, J Geigert
PDA Journal of Pharmaceutical Science and Technology|September 1, 1994
Role of quality control in validation of biopharmaceutical processes: case example of clean-in-place (CIP) procedure for a bioreactorJ Geigert, R Klinke, K Carter, et al.
The Journal of Biological Chemistry|February 25, 1983
Novel haloperoxidase substrates. Alkynes and cyclopropanesJ Geigert, S L Neidleman, D J Dalietos
Pharmaceutical Biotechnology|January 1, 1993
Development and shelf-life determination of recombinant interleukin-2 (proleukin)J Geigert, N Solli, P Woehleke, et al.
Applied and Environmental Microbiology|May 1, 1983
Novel haloperoxidase reaction: synthesis of dihalogenated productsJ Geigert, S L Neidleman, D J Dalietos, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Developments in Biological Standardization|January 1, 1997
Appropriate specifications at the IND stageJ Geigert
PDA Journal of Pharmaceutical Science and Technology|March 1, 1997
Appropriate specifications at the IND stageJ Geigert
Journal of Parenteral Science and Technology : a Publication of the Parenteral Drug Association|September 1, 1989
Overview of the stability and handling of recombinant protein drugsJ Geigert
Biochemical Society Symposium|January 1, 1983
Biological halogenation and epoxidationS L Neidleman, J Geigert
Pharmaceutical Biotechnology|January 1, 1996
Development and shelf-life determination of recombinant human granulocyte--macrophage colony-stimulating factor (LEUKINE, GM-CSF)J Geigert, F D Ghrist
Endeavour|January 1, 1987
Biological halogenation: roles in nature, potential in industryS L Neidleman, J Geigert
PDA Journal of Pharmaceutical Science and Technology|September 1, 1994
Role of quality control in validation of biopharmaceutical processes: case example of clean-in-place (CIP) procedure for a bioreactorJ Geigert, R Klinke, K Carter, et al.
The Journal of Biological Chemistry|February 25, 1983
Novel haloperoxidase substrates. Alkynes and cyclopropanesJ Geigert, S L Neidleman, D J Dalietos
Pharmaceutical Biotechnology|January 1, 1993
Development and shelf-life determination of recombinant interleukin-2 (proleukin)J Geigert, N Solli, P Woehleke, et al.
Applied and Environmental Microbiology|May 1, 1983
Novel haloperoxidase reaction: synthesis of dihalogenated productsJ Geigert, S L Neidleman, D J Dalietos, et al.
Pageof 2